Anthony Goncalves

Département d'Oncologie Médicale, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM UMR1068, CNRS UMR7258, Aix-Marseille Université, Marseille, France.

View Article and Find Full Text PDF

November 2020

Impact of body mass index on overall survival in patients with metastatic breast cancer.

Breast 2020 Dec 1;55:16-24. Epub 2020 Dec 1.

Department of Cancer Medicine, Gustave Roussy, 114 Rue Edouard Vaillant, 94800, Villejuif, France; Department of Medical Oncology, CHU de Limoges, 2 Avenue Martin Luther King, Limoges, France.

View Article and Find Full Text PDF

December 2020

VEGF-Related Germinal Polymorphisms May Identify a Subgroup of Breast Cancer Patients with Favorable Outcome under Bevacizumab-Based Therapy-A Message from COMET, a French Unicancer Multicentric Study.

Pharmaceuticals (Basel) 2020 Nov 23;13(11). Epub 2020 Nov 23.

Medical Oncology Department, Institut Curie, St Cloud, 92210 Paris, France.

View Article and Find Full Text PDF

November 2020

Deterioration of Sexual Health in Cancer Survivors Five Years after Diagnosis: Data from the French National Prospective VICAN Survey.

Authors:

Lorène Seguin Rajae Touzani Anne-Déborah Bouhnik Ali Ben Charif Patricia Marino Marc-Karim Bendiane Anthony Gonçalves Gwenaelle Gravis Julien Mancini

Cancers (Basel) 2020 Nov 20;12(11). Epub 2020 Nov 20.

APHM, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, Equipe CANBIOS Labellisée Ligue Contre le Cancer, Hop Timone, BioSTIC, Biostatistique et Technologies de l'Information et de la Communication, Aix Marseille Univ, 13005 Marseille, France.

View Article and Find Full Text PDF

November 2020

Efficacy of Circulating Tumor Cell Count-Driven vs Clinician-Driven First-line Therapy Choice in Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: The STIC CTC Randomized Clinical Trial.

JAMA Oncol 2020 Nov 5. Epub 2020 Nov 5.

Department of Medical Oncology, Institut Curie, Université de Paris, Paris, France.

View Article and Find Full Text PDF

November 2020

[PARP inhibitors in breast cancer: Current clinical development and perspectives].

Authors:

Julie Robbe Jessica Moretta Cécile Vicier Renaud Sabatier Catherine Noguès Anthony Gonçalves

Bull Cancer 2020 Oct 28;107(10):1024-1041. Epub 2020 Sep 28.

Aix-Marseille Université, Institut Paoli-Calmettes, CNRS, département d'Oncologie Médicale, CRCM, Inserm, 232, boulevard Sainte-Marguerite, BP 156, 13273 Marseille cedex 9, France. Electronic address:

View Article and Find Full Text PDF

October 2020

Combining poly(ADP-ribose) polymerase inhibitors and immune checkpoint inhibitors in breast cancer: rationale and preliminary clinical results.

Authors:

Anthony Goncalves Essia Mezni François Bertucci

Curr Opin Oncol 2020 Nov;32(6):585-593

Medical Oncology Department, Institut Paoli-Calmettes, Aix-Marseille University, INSERM, CNRS, CRCM.

View Article and Find Full Text PDF

November 2020

Palliative care delivery according to age in 12,000 women with metastatic breast cancer: Analysis in the multicentre ESME-MBC cohort 2008-2016.

Eur J Cancer 2020 09 14;137:240-249. Epub 2020 Aug 14.

University of Bordeaux, Inserm, Bordeaux Population Health Research Centre, Epicene Team, UMR 1219, 33000, Bordeaux, France; INSERM CIC1401, Institut Bergonie, Comprehensive Cancer Centre, 33000, Bordeaux, France.

View Article and Find Full Text PDF

September 2020

Adjuvant chemotherapy for small, lymph node-negative, triple-negative breast cancer: A single-center study and a meta-analysis of the published literature.

Authors:

Xin An Xuefen Lei Riqing Huang Rongzhen Luo Haifeng Li Fei Xu Zhongyu Yuan Shusen Wang Alexandre de Nonneville Anthony Gonçalves Gilles Houvenaeghel JiBin Li Cong Xue Yanxia Shi

Cancer 2020 Aug;126 Suppl 16:3837-3846

State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.

View Article and Find Full Text PDF

August 2020

Risk of secondary hematologic malignancies associated with breast cancer chemotherapy and G-CSF support: A nationwide population-based cohort.

Authors:

Marie Joelle Jabagi Norbert Vey Anthony Goncalves Thien Le Tri Mahmoud Zureik Rosemary Dray-Spira

Int J Cancer 2021 Jan 6;148(2):375-384. Epub 2020 Aug 6.

EPI-PHARE (French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM)), Saint-Denis, France.

View Article and Find Full Text PDF

January 2021

Real-world Evaluation of Oral Vinorelbine in the Treatment of Metastatic Breast Cancer: An ESME-MBC Study.

Anticancer Res 2020 Jul;40(7):3905-3913

Biostatistics Department, Centre Léon Bérard, Lyon, France.

View Article and Find Full Text PDF

July 2020

New Therapeutics in HER2-Positive Advanced Breast Cancer: Towards a Change in Clinical Practices?pi.

Authors:

Essia Mezni Cécile Vicier Mathilde Guerin Renaud Sabatier François Bertucci Anthony Gonçalves

Cancers (Basel) 2020 Jun 14;12(6). Epub 2020 Jun 14.

Department of Medical Oncology, Inserm U1068, CNRS UMR7258, Institute Paoli-Calmettes, Aix-Marseille University, 13009 Marseille, France.

View Article and Find Full Text PDF

June 2020

PARP Inhibitors in the Treatment of Early Breast Cancer: The Step Beyond?

Authors:

Anthony Gonçalves Alexandre Bertucci François Bertucci

Cancers (Basel) 2020 May 27;12(6). Epub 2020 May 27.

Medical Oncology Department, Cancer Research Center of Marseille (CRCM), INSERM U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, 13009 Marseille, France.

View Article and Find Full Text PDF

May 2020

Impact of age at diagnosis of metastatic breast cancer on overall survival in the real-life ESME metastatic breast cancer cohort.

Breast 2020 Aug 23;52:50-57. Epub 2020 Apr 23.

Institut Curie, Paris-Saint Cloud, 26, Rue d'Ulm, 75005, Paris, France. Electronic address:

View Article and Find Full Text PDF

August 2020

Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician's Choice Standard-of-Care Chemotherapy.

Authors:

Hope S Rugo Johannes Ettl Sara A Hurvitz Anthony Gonçalves Kyung-Hun Lee Louis Fehrenbacher Lida A Mina Sami Diab Natasha E Woodward Rinat Yerushalmi Annabel Goodwin Joanne L Blum Miguel Martin Ruben G W Quek Iulia Cristina Tudor Helen Bhattacharyya Eric Gauthier Jennifer K Litton Wolfgang Eiermann

JNCI Cancer Spectr 2020 Feb 21;4(1):pkz085. Epub 2019 Oct 21.

Interdisziplinäres Onkologisches Zentrum München, Munich, Germany.

View Article and Find Full Text PDF

February 2020

[COVID-19 and people followed for breast cancer: French guidelines for clinical practice of Nice-St Paul de Vence, in collaboration with the Collège Nationale des Gynécologues et Obstétriciens Français (CNGOF), the Société d'Imagerie de la Femme (SIFEM), the Société Française de Chirurgie Oncologique (SFCO), the Société Française de Sénologie et Pathologie Mammaire (SFSPM) and the French Breast Cancer Intergroup-UNICANCER (UCBG)].

Bull Cancer 2020 05 1;107(5):528-537. Epub 2020 Apr 1.

Institut Gustave-Roussy, Villejuif, France.

View Article and Find Full Text PDF

May 2020

The therapeutic response of ER+/HER2- breast cancers differs according to the molecular Basal or Luminal subtype.

Authors:

François Bertucci Pascal Finetti Anthony Goncalves Daniel Birnbaum

NPJ Breast Cancer 2020 6;6. Epub 2020 Mar 6.

Laboratoire d'Oncologie Prédictive, Centre de Recherche en Cancérologie de Marseille, Inserm U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille Université, Marseille, France.

View Article and Find Full Text PDF

March 2020

Talazoparib in Patients with a Germline BRCA-Mutated Advanced Breast Cancer: Detailed Safety Analyses from the Phase III EMBRACA Trial.

Authors:

Sara A Hurvitz Anthony Gonçalves Hope S Rugo Kyung-Hun Lee Louis Fehrenbacher Lida A Mina Sami Diab Joanne L Blum Jayeta Chakrabarti Mohamed Elmeliegy Liza DeAnnuntis Eric Gauthier Akos Czibere Iulia Cristina Tudor Ruben G W Quek Jennifer K Litton Johannes Ettl

Oncologist 2020 03 25;25(3):e439-e450. Epub 2019 Nov 25.

Department of Obstetrics and Gynecology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.

View Article and Find Full Text PDF

March 2020

Contemporary outcomes of metastatic breast cancer among 22,000 women from the multicentre ESME cohort 2008-2016.

Eur J Cancer 2020 04 2;129:60-70. Epub 2020 Mar 2.

Department of Cancer Medicine, Gustave Roussy, 114 Rue Edouard Vaillant, Villejuif, 94800, France. Electronic address:

View Article and Find Full Text PDF

April 2020

Radiation therapy to the primary tumor for de novo metastatic breast cancer and overall survival in a retrospective multicenter cohort analysis.

Radiother Oncol 2020 Apr 10;145:109-116. Epub 2020 Jan 10.

Medical Oncology Department, Claudius Regaud Institute, IUCT-Oncopole, Toulouse, France.

View Article and Find Full Text PDF

April 2020

High spatial resolution inorganic scintillator detector for high-energy X-ray beam at small field irradiation.

Authors:

Sree Bash Chandra Debnath Carole Fauquet Agnes Tallet Anthony Goncalves Sébastien Lavandier Franck Jandard Didier Tonneau Julien Darreon

Med Phys 2020 Mar 23;47(3):1364-1371. Epub 2020 Jan 23.

Institut Paoli-Calmettes, 13009, Marseille, France.

View Article and Find Full Text PDF

March 2020

NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non-inflammatory breast cancers.

Mol Oncol 2020 03 5;14(3):504-519. Epub 2020 Feb 5.

Translational Cancer Research Unit and Center for Oncological Research (CORE), Faculty of Medicine and Health Sciences, GZA Hospitals Sint-Augustinus and University of Antwerp Wilrijk, Antwerp, Belgium.

View Article and Find Full Text PDF

March 2020

Treatment and outcomes in patients with central nervous system metastases from breast cancer in the real-life ESME MBC cohort.

Eur J Cancer 2020 01 10;125:22-30. Epub 2019 Dec 10.

Department of Research and Development, Unicancer, 101 Rue de Tolbiac, 75654, Paris, France.

View Article and Find Full Text PDF

January 2020

Prognostic value of CEC count in HER2-negative metastatic breast cancer patients treated with bevacizumab and chemotherapy: a prospective validation study (UCBG COMET).

Angiogenesis 2020 05 26;23(2):193-202. Epub 2019 Nov 26.

Department of Medical Oncology, Institut Curie, PSL Research University, 26 rue d'Ulm, 75005, Paris & Saint Cloud, France.

View Article and Find Full Text PDF

May 2020

Talazoparib in Patients with a Germline -Mutated Advanced Breast Cancer: Detailed Safety Analyses from the Phase III EMBRACA Trial.

Authors:

Sara A Hurvitz Anthony Gonçalves Hope S Rugo Kyung-Hun Lee Louis Fehrenbacher Lida A Mina Sami Diab Joanne L Blum Jayeta Chakrabarti Mohamed Elmeliegy Liza DeAnnuntis Eric Gauthier Akos Czibere Iulia Cristina Tudor Ruben G W Quek Jennifer K Litton Johannes Ettl

Oncologist 2019 Nov 25. Epub 2019 Nov 25.

Department of Obstetrics and Gynecology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.

View Article and Find Full Text PDF

November 2019

Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort.

Br J Cancer 2019 12 13;121(12):991-1000. Epub 2019 Nov 13.

Department of Medical Oncology, Centre Léon Bérard, 28 Promenade Léa et Napoléon Bullukian, 69008, Lyon, France.

View Article and Find Full Text PDF

December 2019

Paclitaxel Response Can Be Predicted With Interpretable Multi-Variate Classifiers Exploiting DNA-Methylation and miRNA Data.

Authors:

Alexandra Bomane Anthony Gonçalves Pedro J Ballester

Front Genet 2019 25;10:1041. Epub 2019 Oct 25.

Cancer Research Center of Marseille, CRCM, INSERM, Institut Paoli-Calmettes, Aix-Marseille Univ, CNRS, Paris, France.

View Article and Find Full Text PDF

October 2019

UCBG 2-04: Long-term results of the PACS 04 trial evaluating adjuvant epirubicin plus docetaxel in node-positive breast cancer and trastuzumab in the human epidermal growth factor receptor 2-positive subgroup.

Eur J Cancer 2019 11 18;122:91-100. Epub 2019 Oct 18.

Medical Oncology Department, IUCT Claudius Regaud, Toulouse, France.

View Article and Find Full Text PDF

November 2019

Risk of Hematologic Malignant Neoplasms after Postoperative Treatment of Breast Cancer.

Authors:

Marie Joelle Jabagi Anthony Goncalves Norbert Vey Thien Le Tri Mahmoud Zureik Rosemary Dray-Spira

Cancers (Basel) 2019 Sep 29;11(10). Epub 2019 Sep 29.

EPI-PHARE (French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM)), 143 Boulevard Anatole, 93200 Saint-Denis, France.

View Article and Find Full Text PDF

September 2019

[E-health and "Cancer outside the hospital walls", Big Data and artificial intelligence].

Authors:

François Bertucci Anne-Gaëlle Le Corroller-Soriano Audrey Monneur Sylvain Fluzin Patrice Viens Dominique Maraninchi Anthony Goncalves

Bull Cancer 2020 Jan 19;107(1):102-112. Epub 2019 Sep 19.

Institut Paoli-Calmettes, département d'oncologie médicale, 13009 Marseille, France; Aix-Marseille université, Centre de recherche en cancérologie de Marseille, Inserm U1068-CNRS U7258, 13009 Marseille, France.

View Article and Find Full Text PDF

January 2020

A Tyrosine Kinase Expression Signature Predicts the Post-Operative Clinical Outcome in Triple Negative Breast Cancers.

Authors:

Alexandre de Nonneville Pascal Finetti José Adelaide Éric Lambaudie Patrice Viens Anthony Gonçalves Daniel Birnbaum Emilie Mamessier François Bertucci

Cancers (Basel) 2019 Aug 13;11(8). Epub 2019 Aug 13.

Department of Medical Oncology, Institut Paoli-Calmettes, Aix-Marseille Univ, CRCM, CNRS, INSERM, 13000 Marseille, France.

View Article and Find Full Text PDF

August 2019

PD-1/PD-L1 Targeting in Breast Cancer: The First Clinical Evidences Are Emerging. A Literature Review.

Authors:

Gabrielle Planes-Laine Philippe Rochigneux François Bertucci Anne-Sophie Chrétien Patrice Viens Renaud Sabatier Anthony Gonçalves

Cancers (Basel) 2019 Jul 22;11(7). Epub 2019 Jul 22.

Department of Medical Oncology, Aix-Marseille University, Inserm U1068, CNRS UMR7258, Institute Paoli-Calmettes, 13009 Marseille, France.

View Article and Find Full Text PDF

July 2019

Quality of Life During Chemotherapy for Breast Cancer in a West African Population in Dakar, Senegal: A Prospective Study.

Authors:

Domitille Dano Clémence Hénon Ousseynou Sarr Kanta Ka Mouhamadou Ba Awa Badiane Ibrahima Thiam Papa Diene Mamadou Diop Ahmadou Dem Patricia Marino Julien Mancini Pierre Annede Anthony Gonçalves Doudou Diouf Audrey Monneur

J Glob Oncol 2019 07;5:1-9

Institut Paoli-Calmettes, Marseille, France.

View Article and Find Full Text PDF

July 2019

Efficacy of Vemurafenib in Patients With Non-Small-Cell Lung Cancer With V600 Mutation: An Open-Label, Single-Arm Cohort of the Histology-Independent VE-BASKET Study.

Authors:

Vivek Subbiah Radj Gervais Gregory Riely Antoine Hollebecque Jean-Yves Blay Enriqueta Felip Martin Schuler Anthony Gonçalves Antonio Italiano Vicki Keedy Ian Chau Igor Puzanov Noopur S Raje Funda Meric-Bernstam Martina Makrutzki Todd Riehl Bethany Pitcher Jose Baselga David M Hyman

JCO Precis Oncol 2019 27;3. Epub 2019 Jun 27.

Memorial Sloan Kettering Cancer Center, New York, NY.

View Article and Find Full Text PDF

June 2019

Real-life activity of eribulin mesylate among metastatic breast cancer patients in the multicenter national observational ESME program.

Int J Cancer 2019 12 20;145(12):3359-3369. Epub 2019 Jun 20.

Centre Oscar Lambret, Lille, France.

View Article and Find Full Text PDF

December 2019

A Comparison of DNA Mutation and Copy Number Profiles of Primary Breast Cancers and Paired Brain Metastases for Identifying Clinically Relevant Genetic Alterations in Brain Metastases.

Authors:

Marguerite Tyran Nadine Carbuccia Séverine Garnier Arnaud Guille José Adelaïde Pascal Finetti Julien Toulzian Patrice Viens Agnès Tallet Anthony Goncalves Philippe Metellus Daniel Birnbaum Max Chaffanet François Bertucci

Cancers (Basel) 2019 May 13;11(5). Epub 2019 May 13.

Laboratoire d'Oncologie Prédictive, Centre de Recherche en Cancérologie de Marseille (CRCM), Inserm, U1068, CNRS UMR7258, Aix-Marseille Université, Institut Paoli-Calmettes, F-13009 Marseille, France.

View Article and Find Full Text PDF

May 2019

Stem Cells Inhibition by Bevacizumab in Combination with Neoadjuvant Chemotherapy for Breast Cancer.

Authors:

Renaud Sabatier Emmanuelle Charafe-Jauffret Jean-Yves Pierga Hervé Curé Eric Lambaudie Dominique Genre Gilles Houvenaeghel Patrice Viens Christophe Ginestier François Bertucci Patrick Sfumato Jean-Marc Extra Anthony Gonçalves

J Clin Med 2019 May 6;8(5). Epub 2019 May 6.

Department of Medical Oncology, Institut Paoli-Calmettes, 13009 Marseille, France.

View Article and Find Full Text PDF

May 2019

IMpassion132 Phase III trial: atezolizumab and chemotherapy in early relapsing metastatic triple-negative breast cancer.

Authors:

Javier Cortés Fabrice André Anthony Gonçalves Sherko Kümmel Miguel Martín Peter Schmid Florian Schuetz Sandra M Swain Valerie Easton Erika Pollex Regula Deurloo Rebecca Dent

Future Oncol 2019 Jun 12;15(17):1951-1961. Epub 2019 Apr 12.

Department of Medical Oncology, National Cancer Center, 11 Hospital Drive, Singapore, 169690, Singapore.

View Article and Find Full Text PDF

June 2019

Outpatient Cancer Care Delivery in the Context of E-Oncology: A French Perspective on "Cancer outside the Hospital Walls".

Authors:

François Bertucci Anne-Gaëlle Le Corroller-Soriano Audrey Monneur-Miramon Jean-François Moulin Sylvain Fluzin Dominique Maraninchi Anthony Gonçalves

Cancers (Basel) 2019 Feb 14;11(2). Epub 2019 Feb 14.

Aix-Marseille Univ, INSERM U1068, CNRS UMR7258, Département d'Oncologie Médicale, Institut Paoli-Calmettes, CRCM, 13009 Marseille, France.

View Article and Find Full Text PDF

February 2019

Adjuvant chemotherapy in lobular carcinoma of the breast: a clinicopathological score identifies high-risk patient with survival benefit.

Authors:

Alexandre de Nonneville Camille Jauffret Anthony Gonçalves Jean-Marc Classe Monique Cohen Fabien Reyal Chafika Mazouni Marie-Pierre Chauvet Nicolas Chopin Pierre-Emmanuel Colombo Eva Jouve Emile Darai Roman Rouzier Charles Coutant Pierre Gimbergues Anne-Sophie Azuar Christine Tunon de Lara Eric Lambaudie Gilles Houvenaeghel

Breast Cancer Res Treat 2019 Jun 13;175(2):379-387. Epub 2019 Feb 13.

Department of Surgical Oncology, Aix-Marseille Univ, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Marseille, France.

View Article and Find Full Text PDF

June 2019

Evaluation of the Incidence of Hematologic Malignant Neoplasms Among Breast Cancer Survivors in France.

Authors:

Marie Joelle Jabagi Norbert Vey Anthony Goncalves Thien Le Tri Mahmoud Zureik Rosemary Dray-Spira

JAMA Netw Open 2019 01 4;2(1):e187147. Epub 2019 Jan 4.

Health Product Epidemiology Department, French National Agency for Medicines and Health Products Safety, Saint-Denis, France.

View Article and Find Full Text PDF

January 2019

Targeting Deficiency in Breast Cancer: What are the Clinical Evidences and the Next Perspectives?

Authors:

Emanuel Nicolas François Bertucci Renaud Sabatier Anthony Gonçalves

Cancers (Basel) 2018 Dec 11;10(12). Epub 2018 Dec 11.

Department of Medical Oncology, Institut Paoli-Calmettes, 13009 Marseille, France.

View Article and Find Full Text PDF

December 2018

Survival Impact of Locoregional Treatment of the Primary Tumor in De Novo Metastatic Breast Cancers in a Large Multicentric Cohort Study: A Propensity Score-Matched Analysis.

Ann Surg Oncol 2019 Feb 11;26(2):356-365. Epub 2018 Dec 11.

Department of Medical Oncology, Claudius Regaud Institute, IUCT-Oncopole, Toulouse Cedex 09, France.

View Article and Find Full Text PDF

February 2019

Phase 1b Study of Trebananib Plus Paclitaxel and Trastuzumab in Patients With HER2-Positive Locally Recurrent or Metastatic Breast Cancer.

Authors:

Peter A Kaufman Hans Wildiers Gilles Freyer Margaret Kemeny Anthony Gonçalves Guy Jerusalem Alison Stopeck Nandagopal Vrindavanam Florence Dalenc Nuwan Nanayakkara Benjamin Wu Cheryl A Pickett

Clin Breast Cancer 2019 02 9;19(1):47-57. Epub 2018 Oct 9.

Department of Clinical Development, Amgen Inc, Thousand Oaks, CA.

View Article and Find Full Text PDF

February 2019

Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimens.

Breast Cancer Res Treat 2019 Jan 24;173(2):397-406. Epub 2018 Oct 24.

Institut Curie, 35 rue Dailly, 92210, Saint-Cloud, France.

View Article and Find Full Text PDF

January 2019

Enhancing Abiraterone Acetate Efficacy in Androgen Receptor-positive Triple-negative Breast Cancer: Chk1 as a Potential Target.

Authors:

Thomas Grellety Celine Callens Elodie Richard Adrien Briaux Valérie Vélasco Marina Pulido Anthony Gonçalves Pierre Gestraud Gaetan MacGrogan Hervé Bonnefoi Bruno Cardinaud

Clin Cancer Res 2019 01 23;25(2):856-867. Epub 2018 Oct 23.

Institut National de la Santé et de la Recherche Médicale (INSERM) UNIT U1218, Institut Bergonié, Bordeaux, France.

View Article and Find Full Text PDF

January 2019

Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer.

Oncotarget 2018 Sep 18;9(73):33762-33777. Epub 2018 Sep 18.

Aix-Marseille University, Inserm, CNRS, Institut Paoli-Calmettes, CRCM, Marseille Proteomics, Marseille, France.

View Article and Find Full Text PDF

September 2018

Exploitation of Precision Medicine Trials Data: Examples of Long Responders From the SHIVA01 Trial.

JCO Precis Oncol 2018 19;2. Epub 2018 Oct 19.

, , , , , , , , , , , , , , , , , and , Institut Curie, Paris; , , , , , , , , , , , , , and , Institut Curie; , Institut National de la Santé et de la Recherche Médicale U900 Research Unit, Saint-Cloud; , Institut Paoli-Calmettes, Marseille; , Centre Léon Bérard, Lyon; , Centre Alexis Vautrin, Nancy; , Institut Claudius Régaud, Toulouse; , Centre René Gauducheau, Nantes; , Centre Georges-François Leclerc, Dijon; and , Versailles-Saint-Quentin-en-Yvelines University, Montigny-le-Bretonneux, France.

View Article and Find Full Text PDF

October 2018

Prognostic and predictive factors for angiosarcoma patients receiving paclitaxel once weekly plus or minus bevacizumab: an ancillary study derived from a randomized clinical trial.

Authors:

Loïc Lebellec François Bertucci Emmanuelle Tresch-Bruneel Isabelle Ray-Coquard Axel Le Cesne Emmanuelle Bompas Jean-Yves Blay Antoine Italiano Olivier Mir Thomas Ryckewaert Yves Toiron Luc Camoin Anthony Goncalves Nicolas Penel Marie-Cécile Le Deley

BMC Cancer 2018 Oct 11;18(1):963. Epub 2018 Oct 11.

Direction of Research and Innovation, Centre Oscar Lambret, 3 rue Combemale, 59020, Lille cedex, France.

View Article and Find Full Text PDF

October 2018

Individualized Prediction of Menses Recovery After Chemotherapy for Early-stage Breast Cancer: A Nomogram Developed From UNICANCER PACS04 and PACS05 Trials.

Authors:

Barbara Pistilli Chafika Mazouni Anna Zingarello Matthieu Faron Mahasti Saghatchian Michael Grynberg Marc Spielmann Paul Kerbrat Henri Roché Veronique Lorgis Thomas Bachelot Mario Campone Christelle Levy Anthony Gonçalves Anne Lesur Corinne Veyret Laurence Vanlemmens Jerome Lemonnier Suzette Delaloge

Clin Breast Cancer 2019 02 23;19(1):63-70. Epub 2018 Aug 23.

Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France.

View Article and Find Full Text PDF

February 2019

Isolated ipsilateral local recurrence of breast cancer: predictive factors and prognostic impact.

Breast Cancer Res Treat 2019 Jan 20;173(1):111-122. Epub 2018 Sep 20.

Department of Surgical Oncology, CRCM, Institut Paoli-Calmettes, Aix-Marseille Univ, CNRS, INSERM, 232 Bd de Sainte Marguerite, 13009, Marseille, France.

View Article and Find Full Text PDF

January 2019

Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation.

Authors:

Jennifer K Litton Hope S Rugo Johannes Ettl Sara A Hurvitz Anthony Gonçalves Kyung-Hun Lee Louis Fehrenbacher Rinat Yerushalmi Lida A Mina Miguel Martin Henri Roché Young-Hyuck Im Ruben G W Quek Denka Markova Iulia C Tudor Alison L Hannah Wolfgang Eiermann Joanne L Blum

N Engl J Med 2018 08 15;379(8):753-763. Epub 2018 Aug 15.

From the University of Texas M.D. Anderson Cancer Center, Houston (J.K.L.), and the Texas Oncology-Baylor Charles A. Sammons Cancer Center, US Oncology Network, Dallas (J.L.B.) - both in Texas; University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center (H.S.R.), and Pfizer (R.G.W.Q., D.M., I.C.T., A.L.H.), San Francisco, University of California, Los Angeles, Los Angeles (S.A.H.), and Kaiser Permanente, Northern California, Vallejo (L.F.) - all in California; the Department of Obstetrics and Gynecology, Klinikum Rechts der Isar, Technische Universität München (J.E.), and Interdisziplinäres Onkologisches Zentrum München (W.E.) - both in Munich, Germany; Institut Paoli-Calmettes, Marseille (A.G.), and Institut Claudius Regaud, Institut Universitaire du Cancer Toulouse, Toulouse (H.R.) - both in France; Seoul National University Hospital (K.-H.L.) and Samsung Medical Center (Y.-H.I.) - both in Seoul, South Korea; Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel (R.Y.); Banner M.D. Anderson Cancer Center, Gilbert, AZ (L.A.M.); and Instituto de Investigación Sanitaria Gregorio Marañón, Centro de Investigación Biomédica en Red Oncología, Grupo Español de Investigación en Cáncer de Mama, Universidad Complutense, Madrid (M.M.).

View Article and Find Full Text PDF

August 2018

Réponse à la lettre d’A. Braillon et F. Taiebi.

Authors:

Alexandre de Nonneville Anthony Gonçalves

Bull Cancer 2018 Jul - Aug;105(7-8):641-642. Epub 2018 Jun 22.

Aix-Marseille université, CNRS, Inserm, institut Paoli-Calmettes, département d'oncologie médicale, CRCM, 232, boulevard de Sainte-Marguerite, 13009 Marseille, France. Electronic address:

View Article and Find Full Text PDF

June 2018

[CDK4/6 inhibitors: biomarkers, mechanisms of resistance and interest of the study of the circulating tumor DNA].

Authors:

Anthony Gonçalves

Bull Cancer 2018 Jun 2;105(6):545-546. Epub 2018 May 2.

Institut Paoli-Calmettes, département d'oncologie médicale, 232, boulevard de Sainte-Marguerite, Marseille, France. Electronic address:

View Article and Find Full Text PDF

June 2018

A phase 1 study of lirilumab (antibody against killer immunoglobulin-like receptor antibody KIR2D; IPH2102) in patients with solid tumors and hematologic malignancies.

Authors:

Norbert Vey Lionel Karlin Sophie Sadot-Lebouvier Florence Broussais Dominique Berton-Rigaud Jérôme Rey Aude Charbonnier Delphine Marie Pascale André Carine Paturel Robert Zerbib Jaafar Bennouna Gilles Salles Anthony Gonçalves

Oncotarget 2018 Apr 3;9(25):17675-17688. Epub 2018 Apr 3.

Institut Paoli-Calmettes, Marseille, France.

View Article and Find Full Text PDF

April 2018

Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort.

Eur J Cancer 2018 06 13;96:17-24. Epub 2018 Apr 13.

Department of Cancer Medicine, Gustave Roussy, 114 Rue Edouard Vaillant, 94800 Villejuif, France. Electronic address:

View Article and Find Full Text PDF

June 2018

[Homeopathy in cancer patients: What does the "best" evidence tell us?]

Authors:

Alexandre de Nonneville Anthony Gonçalves

Bull Cancer 2018 Apr 24;105(4):426-430. Epub 2018 Feb 24.

Aix-Marseille université, institut Paoli-Calmettes, department of medical oncology, CNRS, Inserm, CRCM, 13009 Marseille, France.

View Article and Find Full Text PDF

April 2018

[PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer].

Authors:

Audrey Monneur Anthony Gonçalves François Bertucci

Bull Cancer 2018 Mar 16;105(3):263-274. Epub 2018 Feb 16.

Institut Paoli-Calmettes, département d'oncologie médicale, 232, boulevard de Sainte-Marguerite, 13009 Marseille, France; Aix-Marseille université, centre de recherche en cancérologie de Marseille, Inserm U1068-CNRS U7258, 232, boulevard de Sainte-Marguerite, 13009 Marseille, France; Aix-Marseille université, 13009 Marseille, France.

View Article and Find Full Text PDF

March 2018

Safety Results and Analysis of Eribulin Efficacy according to Previous Microtubules-Inhibitors Sensitivity in the French Prospective Expanded Access Program for Heavily Pre-treated Metastatic Breast Cancer.

Authors:

Renaud Sabatier Véronique Diéras Xavier Pivot Etienne Brain Henri Roché Jean-Marc Extra Audrey Monneur Magali Provansal Carole Tarpin François Bertucci Patrice Viens Christophe Zemmour Anthony Gonçalves

Cancer Res Treat 2018 Oct 28;50(4):1226-1237. Epub 2017 Dec 28.

Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.

View Article and Find Full Text PDF

October 2018

[Hot topics in 2017 in oncology and hematology. A selection by the editorial board of Bulletin du Cancer].

Authors:

Stéphane Vignot Thierry André Christophe Caux Carole Bouleuc Serge Evrard Anthony Gonçalves Magali Lacroix Nicolas Magné Christophe Massard Jean-Jacques Mazeron Daniel Orbach Manuel Rodrigues Juliette Thariat Marie Wislez Gilles L'Allemain Jacques-Olivier Bay

Bull Cancer 2018 Jan;105(1):6-14

CHU de Clermont-Ferrand, service de thérapie cellulaire et d'hématologie clinique adulte, 1, place Lucie-Aubrac, 63003 Clermont-Ferrand cedex 1, France.

View Article and Find Full Text PDF

January 2018

Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts.

Cell Rep 2017 Nov;21(9):2458-2470

Centre de Recherche en Cancérologie de Marseille (CRCM), INSERM U1068, CNRS UMR 7258, Institut Paoli-Calmettes, Aix Marseille Université, Marseille, France. Electronic address:

View Article and Find Full Text PDF

November 2017

Safety and efficacy of eribulin for "real-world" older patients with metastatic breast cancer.

Authors:

Alexandre de Nonneville Renaud Sabatier Anthony Gonçalves Jean-Marc Extra Carole Tarpin Simon Launay Louis Tassy Patrice Viens Frederique Rousseau

J Geriatr Oncol 2018 05 22;9(3):281-283. Epub 2017 Nov 22.

Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.

View Article and Find Full Text PDF

May 2018

Similar response profile to neoadjuvant chemotherapy, but different survival, in inflammatory locally advanced breast cancers.

Authors:

Audrey Monneur Anthony Goncalves Marine Gilabert Pascal Finetti Carole Tarpin Christophe Zemmour Jean-Marc Extra Agnès Tallet Eric Lambaudie Jocelyne Jacquemier Gilles Houvenaeghel Jean-Marie Boher Patrice Viens François Bertucci

Oncotarget 2017 Sep 31;8(39):66019-66032. Epub 2017 Jul 31.

Département d'Oncologie Médicale, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, Marseille, France.

View Article and Find Full Text PDF

September 2017

PIKHER2: A phase IB study evaluating buparlisib in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer.

Authors:

Mathilde Guerin Keyvan Rezai Nicolas Isambert Mario Campone Aurélie Autret Jihane Pakradouni Magali Provansal Jacques Camerlo Renaud Sabatier François Bertucci Emmanuelle Charafe-Jauffret Alice Hervieu Jean-Marc Extra Patrice Viens François Lokiec Jean-Marie Boher Anthony Gonçalves

Eur J Cancer 2017 11 23;86:28-36. Epub 2017 Sep 23.

Aix-Marseille University, CNRS, INSERM, Institut Paoli-Calmettes, Department of Medical Oncology, CRCM, Marseille, France. Electronic address:

View Article and Find Full Text PDF

November 2017

Immunotherapy in Breast Cancer: the Emerging Role of PD-1 and PD-L1.

Authors:

François Bertucci Anthony Gonçalves

Curr Oncol Rep 2017 Aug 10;19(10):64. Epub 2017 Aug 10.

Department of Medical Oncology, Institut Paoli-Calmettes, 232 Bd. Ste-Marguerite, 13009, Marseille, France.

View Article and Find Full Text PDF

August 2017

Safety, tolerability and antitumour activity of LY2780301 (p70S6K/AKT inhibitor) in combination with gemcitabine in molecularly selected patients with advanced or metastatic cancer: a phase IB dose escalation study.

Authors:

Eric Angevin Philippe A Cassier Antoine Italiano Anthony Gonçalves Anas Gazzah Catherine Terret Maud Toulmonde Gwenaëlle Gravis Andrea Varga Cédric Parlavecchio Angelo Paci Vianney Poinsignon Jean-Charles Soria Damien Drubay Antoine Hollebecque

Eur J Cancer 2017 09 24;83:194-202. Epub 2017 Jul 24.

Gustave Roussy, Université Paris-Saclay, Drug Development Department (DITEP), Villejuif, F-94805, France. Electronic address:

View Article and Find Full Text PDF

September 2017

The use of systemic therapies to prevent progression of inflammatory breast cancer: which targeted therapies to add on cytotoxic combinations?

Authors:

Anthony Gonçalves Audrey Monneur Patrice Viens François Bertucci

Expert Rev Anticancer Ther 2017 07 25;17(7):593-606. Epub 2017 May 25.

a Department of Medical Oncology, Institut Paoli-Calmettes, Aix Marseille Univ , CNRS U7258, INSERM U1068, CRCM , Marseille , France.

View Article and Find Full Text PDF

July 2017

New advances in DPYD genotype and risk of severe toxicity under capecitabine.

PLoS One 2017 8;12(5):e0175998. Epub 2017 May 8.

Centre Antoine Lacassagne, Nice, France.

View Article and Find Full Text PDF

September 2017

Therapeutic escalation - De-escalation: Data from 15.508 early breast cancer treated with upfront surgery and sentinel lymph node biopsy (SLNB).

Breast 2017 Aug 3;34:24-33. Epub 2017 May 3.

Institut Paoli Calmettes and CRCM, 232 Bd Ste Marguerite, Marseille, France; Aix Marseille Université, Faculté Timone, 25 Boulevard Jean Moulin, Marseille, France.

View Article and Find Full Text PDF

August 2017

Higher antitumor activity of trabectedin in germline BRCA2 carriers with advanced breast cancer as compared to BRCA1 carriers: A subset analysis of a dedicated phase II trial.

Authors:

Amal Ghouadni Suzette Delaloge Pilar Lardelli Carmen Kahatt Tomasz Byrski Joanne L Blum Anthony Gonçalves Mario Campone Antonio Nieto Vicente Alfaro Martin Cullell-Young Jan Lubinski

Breast 2017 Aug 30;34:18-23. Epub 2017 Apr 30.

Pomeranian Medical University, International Hereditary Cancer Center, Sczeczin, Poland. Electronic address:

View Article and Find Full Text PDF

August 2017

[Impact of Her2 and BRCA1/2 status in high-dose chemotherapy and autologous stem cells transplantation in the treatment of breast cancer: The Institut Paoli Calmettes' experience].

Authors:

Laurys Boudin Christian Chabannon Patrick Sfumato Renaud Sabatier François Bertucci Carole Tarpin Magali Provansal Gilles Houvenaeghel Eric Lambaudie Agnes Tallet Michel Resbeut Emmanuelle Charafe-Jauffret Boris Calmels Claude Lemarie Jean-Marie Boher Jean-Marc Extra Patrice Viens Anthony Gonçalves

Bull Cancer 2017 Apr 16;104(4):332-343. Epub 2017 Feb 16.

Institut Paoli-Calmettes (IPC), département d'oncologie médicale, 232, boulevard de Sainte-Marguerite, 13009 Marseille cedex 9, France; Centre de recherches en cancérologie de Marseille (CRCM), UMR Inserm 1068/CNRS 7258/AMU 105/IPC, 232, boulevard de Sainte-Marguerite, 13009 Marseille, France; Aix-Marseille université, Jardin du Pharo, 58, boulevard Charles-Livon, 13284 Marseille, France. Electronic address:

View Article and Find Full Text PDF

April 2017

Marketing Authorization Procedures for Advanced Cancer Drugs: Exploring the Views of Patients, Oncologists, Healthcare Decision Makers, and Citizens in France.

Authors:

Christel Protiére Rachel Baker Dominique Genre Anthony Goncalves Patrice Viens

Med Decis Making 2017 07 15;37(5):555-566. Epub 2017 Feb 15.

Institut Paoli Calmettes, Department of Molecular Oncology, and CRCM, Inserm, U1068; Aix-Marseille Université, UM 105; CNRS, UMR7258, F-13009, Marseille, France (AG, PV).

View Article and Find Full Text PDF

July 2017

Benefit of adjuvant chemotherapy with or without trastuzumab in pT1ab node-negative human epidermal growth factor receptor 2-positive breast carcinomas: results of a national multi-institutional study.

Breast Cancer Res Treat 2017 04 2;162(2):307-316. Epub 2017 Feb 2.

Aix-Marseille University, Marseille, France.

View Article and Find Full Text PDF

April 2017

[Cancer medicines: reasons for anger].

Authors:

Anthony Gonçalves Dominique Maraninchi Jean-Paul Vernant

Rev Prat 2017 02;67(2):141-145

Service d'hématologie clinique, hôpital Pitié-Salpêtrière, université Pierre-et-Marie-Curie, Paris, France.

View Article and Find Full Text PDF

February 2017

Bevacizumab in HER2-negative inflammatory breast cancer.

Authors:

François Bertucci Anthony Goncalves Patrice Viens

Oncoscience 2016 15;3(11-12):297-298. Epub 2016 Nov 15.

Department of Medical Oncology, Centre de Recherche en Cancérologie de Marseille, Institut Paoli-Calmettes, Aix-Marseille University, Marseille, France.

View Article and Find Full Text PDF

November 2016

[Erratum to: "Breast cancer screening: On our way to the future" [Bull. Cancer 103 (2016) 753-763]].

Bull Cancer 2016 11 28;103(11):951-952. Epub 2016 Oct 28.

Université de recherche Paris, sciences et lettres, institut Curie, 26, rue d'Ulm, 75005 Paris, France; Institut Curie, Saint-Cloud, 35, rue Dailly, 92210 Saint-Cloud, France; Université Versailles-Saint-Quentin, 78180 Montigny-le-Bretonneux, France.

View Article and Find Full Text PDF

November 2016

Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis.

PLoS Med 2016 Dec 27;13(12):e1002201. Epub 2016 Dec 27.

INSERM Unit U981, Gustave Roussy, Villejuif, France.

View Article and Find Full Text PDF

December 2016

[Which recent results in Oncology and Hematology will have an impact on our practices? The point of vue of Bulletin du Cancer editorial board].

Authors:

Stéphane Vignot Thierry André Anthony Gonçalves Romain Guièze Nicolas Magné Daniel Orbach Nicolas Penel Juliette Thariat Marie Wislez Jacques-Olivier Bay

Bull Cancer 2017 Jan 19;104(1):6-19. Epub 2016 Dec 19.

CHU de Clermont-Ferrand, service de thérapie cellulaire et d'hématologie clinique adulte, 1, place Lucie-Aubrac, 63003 Clermont-Ferrand cedex 1, France.

View Article and Find Full Text PDF

January 2017

A Phase I Pharmacokinetic Study of Trastuzumab Emtansine (T-DM1) in Patients with Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic Function.

Authors:

Chunze Li Priya Agarwal Ekaterina Gibiansky Jin Yan Jin Susan Dent Anthony Gonçalves Ihsan Nijem Alexander Strasak Marie-Laurence Harle-Yge Nataliya Chernyukhin Pat LoRusso Sandhya Girish

Clin Pharmacokinet 2017 09;56(9):1069-1080

Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA.

View Article and Find Full Text PDF

September 2017

Prognostic impact of hormone receptor- and HER2-defined subtypes in inflammatory breast cancer treated with high-dose chemotherapy: a retrospective study.

Authors:

Laurys Boudin Anthony Gonçalves Patrick Sfumato Renaud Sabatier François Bertucci Carole Tarpin Magali Provansal Gilles Houvenaeghel Eric Lambaudie Agnes Tallet Michel Resbeut Emmanuelle Charafe-Jauffret Boris Calmels Claude Lemarie Jean-Marie Boher Jean-Marc Extra Patrice Viens Christian Chabannon

J Cancer 2016 23;7(14):2077-2084. Epub 2016 Oct 23.

Aix-Marseille Université, Marseille, F-13284, France.; Centre de Thérapie Cellulaire, Département de Biologie du Cancer, Institut Paoli-Calmettes, Marseille, F-13273, France.; Centre d'Investigations Cliniques en Biothérapies, Inserm CBT-1409, Marseille, F-13009, France.

View Article and Find Full Text PDF

October 2016

How may targeted proteomics complement genomic data in breast cancer?

Authors:

Mathilde Guerin Anthony Gonçalves Yves Toiron Emilie Baudelet Stéphane Audebert Jean-Baptiste Boyer Jean-Paul Borg Luc Camoin

Expert Rev Proteomics 2017 01 15;14(1):43-54. Epub 2016 Nov 15.

a Aix Marseille Univ, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Marseille Protéomique , Marseille , France.

View Article and Find Full Text PDF

January 2017

Targeted NGS, array-CGH, and patient-derived tumor xenografts for precision medicine in advanced breast cancer: a single-center prospective study.

Oncotarget 2016 Nov;7(48):79428-79441

Aix Marseille Univ, CNRS U7258, INSERM U1068, Institut Paoli-Calmettes, CRCM, Marseille, France.

View Article and Find Full Text PDF

November 2016

Corrigendum to "Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation" [Eur J Cancer 57 (April 2016) 118-126].

Authors:

Laurys Boudin Christian Chabannon Patrick Sfumato Renaud Sabatier François Bertucci Carole Tarpin Magali Provansal Gilles Houvenaeghel Eric Lambaudie Agnes Tallet Michel Resbeut Emmanuelle Charafe-Jauffret Boris Calmels Claude Lemarie Jean-Marie Boher Jean-Marc Extra Patrice Viens Anthony Gonçalves

Eur J Cancer 2016 11 24;67:223. Epub 2016 Sep 24.

Département d'Oncologie Médicale, Institut Paoli-Calmettes (IPC), Marseille, F-13273, France; Centre de Recherches en Cancérologie de Marseille (CRCM), UMR Inserm 1068/CNRS 7258/AMU 105/IPC, Marseille, F-13009, France; Aix-Marseille Université, Marseille, F-13284, France. Electronic address:

View Article and Find Full Text PDF

November 2016

Circulating vascular endothelial growth factor (VEGF) as predictive factor of progression-free survival in patients with advanced chordoma receiving sorafenib: an analysis from a phase II trial of the french sarcoma group (GSF/GETO).

Authors:

Loic Lebellec François Bertucci Emmanuelle Tresch-Bruneel Emmanuelle Bompas Yves Toiron Luc Camoin Olivier Mir Valerie Laurence Stephanie Clisant Emilie Decoupigny Jean-Yves Blay Anthony Goncalves Nicolas Penel

Oncotarget 2016 Nov;7(45):73984-73994

Department of Medical Oncology, Centre Oscar Lambret, Lille, France.

View Article and Find Full Text PDF

November 2016

[Not Available].

Authors:

Anthony Gonçalves

Bull Cancer 2016 Jun;103(6 Suppl 1):S76-89

Département d'oncologie médicale, Institut Paoli-Calmettes, Marseille, 13009; Centre de recherche en cancérologie de Marseille (Institut Paoli-Calmettes, Inserm 1068, Cnrs 7258, Aix-Marseille Université), Marseille, 13009; Aix-Marseille Université, Marseille, 13006. Electronic address:

View Article and Find Full Text PDF

June 2016

[Breast cancer screening: On our way to the future].

Bull Cancer 2016 09 26;103(9):753-63. Epub 2016 Jul 26.

Université de recherche Paris, sciences et lettres, institut Curie, 26, rue d'Ulm, 75005 Paris, France; Institut Curie, Saint-Cloud, 35, rue Dailly, 92210 Saint-Cloud, France; Université Versailles-Saint-Quentin, 78180 Montigny-le-Bretonneux, France.

View Article and Find Full Text PDF

September 2016

Invasive ductal breast carcinoma with predominant intraductal component: Clinicopathological features and prognosis.

Authors:

Renaud Sabatier Laura Sabiani Christophe Zemmour Sébastien Taix Elisabeth Chereau Anthony Gonçalves Aurélie Jalaguier-Coudray Emmanuelle Charafe-Jauffret Michel Resbeut Jean-Marc Extra Patrice Viens Agnès Tallet

Breast 2016 Jun 19;27:8-14. Epub 2016 Mar 19.

Department of Radiotherapy, Institut Paoli-Calmettes, Marseille, France.

View Article and Find Full Text PDF

June 2016

[Anticancer drugs: Which prices for therapeutic innovations?].

Authors:

Anthony Gonçalves Dominique Maraninchi Patricia Marino

Bull Cancer 2016 Apr 1;103(4):361-7. Epub 2016 Apr 1.

Aix-Marseille université, 13284 Marseille, France; Institut Paoli-Calmettes, Inserm UMR912 SESSTIM, 13009 Marseille, France.

View Article and Find Full Text PDF

April 2016

Comparative genomic analysis of primary tumors and metastases in breast cancer.

Authors:

François Bertucci Pascal Finetti Arnaud Guille José Adélaïde Séverine Garnier Nadine Carbuccia Audrey Monneur Emmanuelle Charafe-Jauffret Anthony Goncalves Patrice Viens Daniel Birnbaum Max Chaffanet

Oncotarget 2016 May;7(19):27208-19

Département d'Oncologie Moléculaire, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Marseille, France.

View Article and Find Full Text PDF

May 2016

[Financial stress: A prognostic factor for cancer survival!].

Authors:

Anthony Gonçalves

Bull Cancer 2016 Apr 24;103(4):318. Epub 2016 Mar 24.

Institut Paoli-Calmettes, centre de recherche en cancérologie de Marseille, Inserm U1068, CNRS U7258, Aix-Marseille Université, 232, boulevard Sainte-Marguerite, 13009 Marseille, France. Electronic address:

View Article and Find Full Text PDF

April 2016

Survival impact and predictive factors of axillary recurrence after sentinel biopsy.

Eur J Cancer 2016 May 11;58:73-82. Epub 2016 Mar 11.

Institut Paoli Calmettes and CRCM, 232 Bd Ste Marguerite, 13009 Marseille, France; Institut Paoli Calmettes, Biostatistic Department, 232 Bd Ste Marguerite, 13009 Marseille, France; Aix Marseille Université, 25 Bd Jean Moulin, 13005 Marseille, France.

View Article and Find Full Text PDF

May 2016

Phase Ib/II study of elisidepsin in metastatic or advanced gastroesophageal cancer (IMAGE trial).

Authors:

Russell Petty Alan Anthoney Jean-Philippe Metges Maria Alsina Anthony Gonçalves Jennifer Brown Clara Montagut Katharina Gunzer Gianluca Laus Jorge Luis Iglesias Dios Bernardo Miguel-Lillo Patrick Bohan Ramón Salazar

Cancer Chemother Pharmacol 2016 Apr 10;77(4):819-27. Epub 2016 Mar 10.

Institut Català d'Oncologia (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.

View Article and Find Full Text PDF

April 2016

MMP2 and MMP9 serum levels are associated with favorable outcome in patients with inflammatory breast cancer treated with bevacizumab-based neoadjuvant chemotherapy in the BEVERLY-2 study.

Oncotarget 2016 Apr;7(14):18531-40

Institut Paoli-Calmettes, Medical Oncology Department, Marseille, France.

View Article and Find Full Text PDF

April 2016

Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation.

Authors:

Laurys Boudin Christian Chabannon Patrick Sfumato Renaud Sabatier François Bertucci Carole Tarpin Magali Provansal Gilles Houvenaeghel Eric Lambaudie Agnes Tallet Michel Resbeut Emmanuelle Charafe-Jauffret Boris Calmels Claude Lemarie Jean-Marie Boher Jean-Marc Extra Patrice Viens Anthony Gonçalves

Eur J Cancer 2016 04 23;57:118-26. Epub 2016 Feb 23.

Département d'Oncologie Médicale, Institut Paoli-Calmettes (IPC), Marseille, F-13273, France; Centre de Recherches en Cancérologie de Marseille (CRCM), UMR Inserm 1068/CNRS 7258/AMU 105/IPC, Marseille, F-13009, France; Aix-Marseille Université, Marseille, F-13284, France. Electronic address:

View Article and Find Full Text PDF

April 2016

[2015 through the eyes of the Bulletin of Cancer editorial board].

Authors:

Nicolas Magné Christophe Massard Jacques-Olivier Bay Thierry André Jean-Yves Blay Anthony Goncalves Daniel Orbach Marie Wislez Juliette Thariat Nicolas Penel Chloé Rancoule Stéphane Vignot

Bull Cancer 2016 Jan 15;103(1):3-17. Epub 2016 Jan 15.

Hôpitaux de Chartres, service oncologie hématologie, , site Louis-Pasteur, 28630 Chartres-Le-Coudray, France.

View Article and Find Full Text PDF

January 2016

Identification of p62/SQSTM1 as a component of non-canonical Wnt VANGL2-JNK signalling in breast cancer.

Nat Commun 2016 Jan 12;7:10318. Epub 2016 Jan 12.

CRCM, Cell Polarity, Cell signalling and Cancer 'Equipe labellisée Ligue Contre le Cancer', Inserm, U1068, Marseille F-13009, France.

View Article and Find Full Text PDF

January 2016

A phase II trial of trabectedin in triple-negative and HER2-overexpressing metastatic breast cancer.

Authors:

Joanne L Blum Anthony Gonçalves Noa Efrat Marc Debled Pierfranco Conte Paul D Richards Donald Richards Pilar Lardelli Antonio Nieto Martin Cullell-Young Suzette Delaloge

Breast Cancer Res Treat 2016 Jan 9;155(2):295-302. Epub 2016 Jan 9.

Gustave Roussy Cancer Campus, Villejuif, France.

View Article and Find Full Text PDF

January 2016

Publications by authors named "Anthony Goncalves"

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors: